Answers are grounded in this paper and cite their sources.
Common variants in TCF7L2 seem to be associated with an increased risk of diabetes among persons with impaired glucose tolerance. The risk-conferring genotypes in TCF7L2 are associated with impaired beta-cell function but not with insulin resistance. (ClinicalTrials.gov number, NCT00004992. [ClinicalTrials.gov]).
No takes yet. Share an insight, caveat, or question.
Florez et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: